For influenza prophylaxis in accordance with NICE TA158 and NICE TA168. 

For the treatment of influenza out of flu season, please search the term "fluoos" in the search bar and follow the guidance provided.  

For the treatment of influenza in adults and children if all the following circumstances apply:

•national surveillance schemes indicate that influenza virus A or B is circulating
•the person is in an 'at-risk' group as defined in the guidance
•the person presents with an influenza-like illness and can start treatment within 48 hours (or within 36 hours for zanamivir treatment in children) of the onset of symptoms as per licensed indications.

Vaccination, particularly targeting "high risk" patients, remains the mainstay of influenza management.

For influenza prophylaxis and treatment in accordance with NICE recommendations (TAs 158 and 168).

For the treatment of influenza in adults and children if all the following circumstances apply:

•national surveillance schemes indicate that influenza virus A or B is circulating
•the person is in an 'at-risk' group as defined in the guidance
•the person presents with an influenza-like illness and can start treatment within 48 hours (or within 36 hours for zanamivir treatment in children) of the onset of symptoms as per licensed indications.


Vaccination particularly targeting 'high risk' patients remains the mainstay of influenza management.

May be obtained from GSK on compassionate grounds for named patients for nebulistation or IV administration - for criteria see latest DH guidelines